Home›Companies›Biotech & Pharma›Kytopen

Kytopen Corp.

Updated Oct 27, 2026·Latest SEC filing Feb 20, 2025·Suggest an edit

About Kytopen

Kytopen is a private company based in Cambridge, Massachusetts. It has reported $52,707,234 raised in five offerings on Form D since May 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 6, 2025Feb 20, 2025$7,082,651of $15.0M target13$544KEquity, Series AA Preferred StockRule 506(b)Form D ↗
Jan 31, 2024Feb 15, 2024$5,691,637of $8.0M target22$258KDebt, Options, Convertible Unsecured Promissory NotesRule 506(b)Form D ↗
Sep 27, 2021Oct 8, 2021$32,479,963fully sold18$1.8MEquity, Series A Preferred StockRule 506(b)Form D ↗
Oct 26, 2020Nov 6, 2020$3,102,983of $4.0M target11$282KEquity, Series Seed-3 Preferred StockRule 506(b)Form D ↗
May 10, 2019May 24, 2019$4,350,000fully sold9$483KEquity, Series Seed - 1 Preferred Stock and Series Seed - 2 Preferred StockRule 506(b)Form D ↗
Total, five offerings$52,707,234

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Kytopen's Form D filed Feb 20, 2025.

CB
Cullen Buie
Director
JV
Julio Vega
Executive officer
MC
Michael Chiu
Executive officer and director
PW
Paul Wotton
Director
PM
Paxton Major
Director

Earlier filings also listed Edward Freedman (director, last listed Feb 2024), Bethany Grant (executive officer, last listed Feb 2024), Theresa Tribble (director, last listed Oct 2021), Paulo Garcia (executive officer, director and promoter, last listed Oct 2021), Adam Wieschhaus (director, last listed Oct 2021) and Ann DeWitt (director, last listed Nov 2020).

Sources

  1. SECKytopen Corp. filing history